BIOMAT Database Logo BIOMAT Database Logo

Timing of breast cancer surgery within the menstrual cycle: tumor proliferative activity, receptor status and short-term clinical outcome. 1998

A Mangia, and M De Lena, and A Barletta, and F Marzullo, and M Attolico, and B Stea, and S Petroni, and A Labriola, and G Cellamare, and G Digiesi, and R Altieri, and F Schittulli, and A Paradiso
Experimental and Clinical Oncology Laboratory, Oncology Institute, Bari, Italy.

We verified the variations of primary tumour steroid receptor status and proliferative activity at different times and phases (follicular vs luteal) of the menstrual cycle and their relationship with short clinical outcome in a cohort of 248 N- breast cancer patients. Steroid receptor content (ER and PgR) was evaluated by DCC assay and proliferative activity by 3H-Thymidine autoradiographic assay (TLI). Median age was 44 years, 60% of tumors were T1, and cytohistological grade was G1-2 in 54% of cases. At surgery, 57% were in the luteal phase while 43% were in the follicular phase. No significant variations were found in mean TLI or ER and PgR characteristics of the primary tumors surgically treated in different periods of the menstrual cycle; however, the ER level resulted significantly higher in 4th with respect to the 3rd week of menstrual cycle, while PgR level was higher in PgR+ cases treated during the 3rd week. The number of relapses and disease-free survival curves after 36 months median follow-up did not differ significantly for patients treated in different periods of the menstrual cycle (12% and 9% of disease relapses in luteal and follicular phases; p=n.s.). We can conclude, therefore, that TLI, ER and PgR expressions could vary significantly during menstrual cycle only in certain specific tumor subgroups.

UI MeSH Term Description Entries
D008597 Menstrual Cycle The period from onset of one menstrual bleeding (MENSTRUATION) to the next in an ovulating woman or female primate. The menstrual cycle is regulated by endocrine interactions of the HYPOTHALAMUS; the PITUITARY GLAND; the ovaries; and the genital tract. The menstrual cycle is divided by OVULATION into two phases. Based on the endocrine status of the OVARY, there is a FOLLICULAR PHASE and a LUTEAL PHASE. Based on the response in the ENDOMETRIUM, the menstrual cycle is divided into a proliferative and a secretory phase. Endometrial Cycle,Ovarian Cycle,Cycle, Endometrial,Cycle, Menstrual,Cycle, Ovarian,Cycles, Endometrial,Cycles, Menstrual,Cycles, Ovarian,Endometrial Cycles,Menstrual Cycles,Ovarian Cycles
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D011980 Receptors, Progesterone Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives. Progesterone Receptors,Progestin Receptor,Progestin Receptors,Receptor, Progesterone,Receptors, Progestin,Progesterone Receptor,Receptor, Progestin
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast

Related Publications

A Mangia, and M De Lena, and A Barletta, and F Marzullo, and M Attolico, and B Stea, and S Petroni, and A Labriola, and G Cellamare, and G Digiesi, and R Altieri, and F Schittulli, and A Paradiso
The timing of breast cancer surgery within the menstrual cycle.
April 1994, Postgraduate medical journal,
A Mangia, and M De Lena, and A Barletta, and F Marzullo, and M Attolico, and B Stea, and S Petroni, and A Labriola, and G Cellamare, and G Digiesi, and R Altieri, and F Schittulli, and A Paradiso
Timing of breast cancer surgery in the menstrual cycle and outcome.
April 1991, Annals of oncology : official journal of the European Society for Medical Oncology,
A Mangia, and M De Lena, and A Barletta, and F Marzullo, and M Attolico, and B Stea, and S Petroni, and A Labriola, and G Cellamare, and G Digiesi, and R Altieri, and F Schittulli, and A Paradiso
Timing of breast cancer surgery during the menstrual cycle.
January 1994, Annals of oncology : official journal of the European Society for Medical Oncology,
A Mangia, and M De Lena, and A Barletta, and F Marzullo, and M Attolico, and B Stea, and S Petroni, and A Labriola, and G Cellamare, and G Digiesi, and R Altieri, and F Schittulli, and A Paradiso
Timing of breast cancer surgery within the menstrual cycle: influence on lymph-node involvement, receptor status, postoperative metastatic spread and local recurrence.
April 1991, Annals of oncology : official journal of the European Society for Medical Oncology,
A Mangia, and M De Lena, and A Barletta, and F Marzullo, and M Attolico, and B Stea, and S Petroni, and A Labriola, and G Cellamare, and G Digiesi, and R Altieri, and F Schittulli, and A Paradiso
Timing of surgery for breast cancer and menstrual cycle.
August 1991, Lancet (London, England),
A Mangia, and M De Lena, and A Barletta, and F Marzullo, and M Attolico, and B Stea, and S Petroni, and A Labriola, and G Cellamare, and G Digiesi, and R Altieri, and F Schittulli, and A Paradiso
The timing of breast cancer surgery during the menstrual cycle.
October 1997, Oncology (Williston Park, N.Y.),
A Mangia, and M De Lena, and A Barletta, and F Marzullo, and M Attolico, and B Stea, and S Petroni, and A Labriola, and G Cellamare, and G Digiesi, and R Altieri, and F Schittulli, and A Paradiso
Breast cancer surgery: Is timing during the menstrual cycle critical?
January 1991, The National medical journal of India,
A Mangia, and M De Lena, and A Barletta, and F Marzullo, and M Attolico, and B Stea, and S Petroni, and A Labriola, and G Cellamare, and G Digiesi, and R Altieri, and F Schittulli, and A Paradiso
Timing of surgery during the menstrual cycle and prognosis of breast cancer.
March 2000, Journal of biosciences,
A Mangia, and M De Lena, and A Barletta, and F Marzullo, and M Attolico, and B Stea, and S Petroni, and A Labriola, and G Cellamare, and G Digiesi, and R Altieri, and F Schittulli, and A Paradiso
Survival of premenopausal breast carcinoma patients in relation to menstrual cycle timing of surgery and estrogen receptor/progesterone receptor status of the primary tumor.
November 1999, Cancer,
A Mangia, and M De Lena, and A Barletta, and F Marzullo, and M Attolico, and B Stea, and S Petroni, and A Labriola, and G Cellamare, and G Digiesi, and R Altieri, and F Schittulli, and A Paradiso
Breast cancer survival and the timing of tumor removal during the menstrual cycle.
November 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
Copied contents to your clipboard!